We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva

By LabMedica International staff writers
Posted on 01 Jan 2025

Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients. More...

In approximately 20% of these cases, the condition progresses to more severe stages of AKI, leading to longer hospital stays, higher mortality rates, and an increased need for invasive renal replacement therapies. Early intervention, driven by frequent or continuous monitoring of renal function biomarkers like creatinine, could potentially delay this progression. As renal failure can advance quickly, frequent venipuncture for creatinine testing is required. Recent advances in microfluidic devices and biosensors have led to the exploration of alternative biofluids, such as sweat and saliva, for non-invasive, continuous monitoring of creatinine. Researchers have now developed a novel Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) assay for detecting low creatinine levels in these biofluids.

Researchers at Eindhoven University of Technology (Eindhoven, The Netherlandsl) investigated the correlation between creatinine concentrations in sweat, saliva, and plasma during hemodialysis, with an eye toward future biosensor applications. They measured creatinine levels in sweat, saliva, and plasma from 40 patients undergoing hemodialysis. Using the novel LC-MS/MS assay, they quantified low creatinine concentrations in these biofluids. Correlation analyses were conducted to compare creatinine levels across the biofluids. The LC-MS/MS assay demonstrated excellent accuracy (93.9% to 97.8%) and low imprecision (3.4% to 8.1%) for measuring very low creatinine concentrations, with a limit of quantitation of 1.26 µmol/L.

The study revealed strong correlations between creatinine concentrations in sweat and saliva compared to plasma (ρ: 0.68 and 0.80, respectively). During hemodialysis, creatinine concentrations declined similarly across all three biofluids. These strong correlations suggest that sweat and saliva could serve as reliable, non-invasive alternatives to traditional blood tests for assessing kidney function. This research improves the understanding of creatinine excretion pathways and lays the groundwork for the development of patient-friendly, continuous kidney function monitoring methods, such as wearable biosensors.


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.